Global Gabapentin Market Research Report 2024(Status and Outlook)
Report Overview:
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The Global Gabapentin Market Size was estimated at USD 1575.39 million in 2023 and is projected to reach USD 1753.37 million by 2029, exhibiting a CAGR of 1.80% during the forecast period.
This report provides a deep insight into the global Gabapentin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gabapentin Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gabapentin market in any manner.
Global Gabapentin Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Market Segmentation (by Type)
Capsule
Tablet
Market Segmentation (by Application)
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
The Global Gabapentin Market Size was estimated at USD 1575.39 million in 2023 and is projected to reach USD 1753.37 million by 2029, exhibiting a CAGR of 1.80% during the forecast period.
This report provides a deep insight into the global Gabapentin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gabapentin Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gabapentin market in any manner.
Global Gabapentin Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
Market Segmentation (by Type)
Capsule
Tablet
Market Segmentation (by Application)
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gabapentin Market
- Overview of the regional outlook of the Gabapentin Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gabapentin
1.2 Key Market Segments
1.2.1 Gabapentin Segment by Type
1.2.2 Gabapentin Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GABAPENTIN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gabapentin Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gabapentin Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GABAPENTIN MARKET COMPETITIVE LANDSCAPE
3.1 Global Gabapentin Sales by Manufacturers (2019-2024)
3.2 Global Gabapentin Revenue Market Share by Manufacturers (2019-2024)
3.3 Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gabapentin Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gabapentin Sales Sites, Area Served, Product Type
3.6 Gabapentin Market Competitive Situation and Trends
3.6.1 Gabapentin Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gabapentin Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GABAPENTIN INDUSTRY CHAIN ANALYSIS
4.1 Gabapentin Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GABAPENTIN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GABAPENTIN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Sales Market Share by Type (2019-2024)
6.3 Global Gabapentin Market Size Market Share by Type (2019-2024)
6.4 Global Gabapentin Price by Type (2019-2024)
7 GABAPENTIN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Market Sales by Application (2019-2024)
7.3 Global Gabapentin Market Size (M USD) by Application (2019-2024)
7.4 Global Gabapentin Sales Growth Rate by Application (2019-2024)
8 GABAPENTIN MARKET SEGMENTATION BY REGION
8.1 Global Gabapentin Sales by Region
8.1.1 Global Gabapentin Sales by Region
8.1.2 Global Gabapentin Sales Market Share by Region
8.2 North America
8.2.1 North America Gabapentin Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gabapentin Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gabapentin Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gabapentin Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gabapentin Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Gabapentin Basic Information
9.1.2 Pfizer Gabapentin Product Overview
9.1.3 Pfizer Gabapentin Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Gabapentin SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Assertio Therapeutics
9.2.1 Assertio Therapeutics Gabapentin Basic Information
9.2.2 Assertio Therapeutics Gabapentin Product Overview
9.2.3 Assertio Therapeutics Gabapentin Product Market Performance
9.2.4 Assertio Therapeutics Business Overview
9.2.5 Assertio Therapeutics Gabapentin SWOT Analysis
9.2.6 Assertio Therapeutics Recent Developments
9.3 TEVA
9.3.1 TEVA Gabapentin Basic Information
9.3.2 TEVA Gabapentin Product Overview
9.3.3 TEVA Gabapentin Product Market Performance
9.3.4 TEVA Gabapentin SWOT Analysis
9.3.5 TEVA Business Overview
9.3.6 TEVA Recent Developments
9.4 Mylan
9.4.1 Mylan Gabapentin Basic Information
9.4.2 Mylan Gabapentin Product Overview
9.4.3 Mylan Gabapentin Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Recent Developments
9.5 Arbor Pharma
9.5.1 Arbor Pharma Gabapentin Basic Information
9.5.2 Arbor Pharma Gabapentin Product Overview
9.5.3 Arbor Pharma Gabapentin Product Market Performance
9.5.4 Arbor Pharma Business Overview
9.5.5 Arbor Pharma Recent Developments
9.6 Novartis
9.6.1 Novartis Gabapentin Basic Information
9.6.2 Novartis Gabapentin Product Overview
9.6.3 Novartis Gabapentin Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Apotex
9.7.1 Apotex Gabapentin Basic Information
9.7.2 Apotex Gabapentin Product Overview
9.7.3 Apotex Gabapentin Product Market Performance
9.7.4 Apotex Business Overview
9.7.5 Apotex Recent Developments
9.8 Sun Pharmaceutical
9.8.1 Sun Pharmaceutical Gabapentin Basic Information
9.8.2 Sun Pharmaceutical Gabapentin Product Overview
9.8.3 Sun Pharmaceutical Gabapentin Product Market Performance
9.8.4 Sun Pharmaceutical Business Overview
9.8.5 Sun Pharmaceutical Recent Developments
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Gabapentin Basic Information
9.9.2 Aurobindo Pharma Gabapentin Product Overview
9.9.3 Aurobindo Pharma Gabapentin Product Market Performance
9.9.4 Aurobindo Pharma Business Overview
9.9.5 Aurobindo Pharma Recent Developments
9.10 Intas
9.10.1 Intas Gabapentin Basic Information
9.10.2 Intas Gabapentin Product Overview
9.10.3 Intas Gabapentin Product Market Performance
9.10.4 Intas Business Overview
9.10.5 Intas Recent Developments
9.11 Amneal
9.11.1 Amneal Gabapentin Basic Information
9.11.2 Amneal Gabapentin Product Overview
9.11.3 Amneal Gabapentin Product Market Performance
9.11.4 Amneal Business Overview
9.11.5 Amneal Recent Developments
9.12 Marksans Pharma
9.12.1 Marksans Pharma Gabapentin Basic Information
9.12.2 Marksans Pharma Gabapentin Product Overview
9.12.3 Marksans Pharma Gabapentin Product Market Performance
9.12.4 Marksans Pharma Business Overview
9.12.5 Marksans Pharma Recent Developments
9.13 Glenmark
9.13.1 Glenmark Gabapentin Basic Information
9.13.2 Glenmark Gabapentin Product Overview
9.13.3 Glenmark Gabapentin Product Market Performance
9.13.4 Glenmark Business Overview
9.13.5 Glenmark Recent Developments
9.14 Alkem
9.14.1 Alkem Gabapentin Basic Information
9.14.2 Alkem Gabapentin Product Overview
9.14.3 Alkem Gabapentin Product Market Performance
9.14.4 Alkem Business Overview
9.14.5 Alkem Recent Developments
9.15 Jiangsu Enhua
9.15.1 Jiangsu Enhua Gabapentin Basic Information
9.15.2 Jiangsu Enhua Gabapentin Product Overview
9.15.3 Jiangsu Enhua Gabapentin Product Market Performance
9.15.4 Jiangsu Enhua Business Overview
9.15.5 Jiangsu Enhua Recent Developments
9.16 Jiangsu Hengrui
9.16.1 Jiangsu Hengrui Gabapentin Basic Information
9.16.2 Jiangsu Hengrui Gabapentin Product Overview
9.16.3 Jiangsu Hengrui Gabapentin Product Market Performance
9.16.4 Jiangsu Hengrui Business Overview
9.16.5 Jiangsu Hengrui Recent Developments
9.17 Sailike
9.17.1 Sailike Gabapentin Basic Information
9.17.2 Sailike Gabapentin Product Overview
9.17.3 Sailike Gabapentin Product Market Performance
9.17.4 Sailike Business Overview
9.17.5 Sailike Recent Developments
10 GABAPENTIN MARKET FORECAST BY REGION
10.1 Global Gabapentin Market Size Forecast
10.2 Global Gabapentin Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gabapentin Market Size Forecast by Country
10.2.3 Asia Pacific Gabapentin Market Size Forecast by Region
10.2.4 South America Gabapentin Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gabapentin by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gabapentin Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gabapentin by Type (2025-2030)
11.1.2 Global Gabapentin Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gabapentin by Type (2025-2030)
11.2 Global Gabapentin Market Forecast by Application (2025-2030)
11.2.1 Global Gabapentin Sales (Kilotons) Forecast by Application
11.2.2 Global Gabapentin Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gabapentin
1.2 Key Market Segments
1.2.1 Gabapentin Segment by Type
1.2.2 Gabapentin Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GABAPENTIN MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gabapentin Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gabapentin Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GABAPENTIN MARKET COMPETITIVE LANDSCAPE
3.1 Global Gabapentin Sales by Manufacturers (2019-2024)
3.2 Global Gabapentin Revenue Market Share by Manufacturers (2019-2024)
3.3 Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gabapentin Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gabapentin Sales Sites, Area Served, Product Type
3.6 Gabapentin Market Competitive Situation and Trends
3.6.1 Gabapentin Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gabapentin Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GABAPENTIN INDUSTRY CHAIN ANALYSIS
4.1 Gabapentin Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GABAPENTIN MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GABAPENTIN MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Sales Market Share by Type (2019-2024)
6.3 Global Gabapentin Market Size Market Share by Type (2019-2024)
6.4 Global Gabapentin Price by Type (2019-2024)
7 GABAPENTIN MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Market Sales by Application (2019-2024)
7.3 Global Gabapentin Market Size (M USD) by Application (2019-2024)
7.4 Global Gabapentin Sales Growth Rate by Application (2019-2024)
8 GABAPENTIN MARKET SEGMENTATION BY REGION
8.1 Global Gabapentin Sales by Region
8.1.1 Global Gabapentin Sales by Region
8.1.2 Global Gabapentin Sales Market Share by Region
8.2 North America
8.2.1 North America Gabapentin Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gabapentin Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gabapentin Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gabapentin Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gabapentin Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Gabapentin Basic Information
9.1.2 Pfizer Gabapentin Product Overview
9.1.3 Pfizer Gabapentin Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Gabapentin SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Assertio Therapeutics
9.2.1 Assertio Therapeutics Gabapentin Basic Information
9.2.2 Assertio Therapeutics Gabapentin Product Overview
9.2.3 Assertio Therapeutics Gabapentin Product Market Performance
9.2.4 Assertio Therapeutics Business Overview
9.2.5 Assertio Therapeutics Gabapentin SWOT Analysis
9.2.6 Assertio Therapeutics Recent Developments
9.3 TEVA
9.3.1 TEVA Gabapentin Basic Information
9.3.2 TEVA Gabapentin Product Overview
9.3.3 TEVA Gabapentin Product Market Performance
9.3.4 TEVA Gabapentin SWOT Analysis
9.3.5 TEVA Business Overview
9.3.6 TEVA Recent Developments
9.4 Mylan
9.4.1 Mylan Gabapentin Basic Information
9.4.2 Mylan Gabapentin Product Overview
9.4.3 Mylan Gabapentin Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Recent Developments
9.5 Arbor Pharma
9.5.1 Arbor Pharma Gabapentin Basic Information
9.5.2 Arbor Pharma Gabapentin Product Overview
9.5.3 Arbor Pharma Gabapentin Product Market Performance
9.5.4 Arbor Pharma Business Overview
9.5.5 Arbor Pharma Recent Developments
9.6 Novartis
9.6.1 Novartis Gabapentin Basic Information
9.6.2 Novartis Gabapentin Product Overview
9.6.3 Novartis Gabapentin Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Apotex
9.7.1 Apotex Gabapentin Basic Information
9.7.2 Apotex Gabapentin Product Overview
9.7.3 Apotex Gabapentin Product Market Performance
9.7.4 Apotex Business Overview
9.7.5 Apotex Recent Developments
9.8 Sun Pharmaceutical
9.8.1 Sun Pharmaceutical Gabapentin Basic Information
9.8.2 Sun Pharmaceutical Gabapentin Product Overview
9.8.3 Sun Pharmaceutical Gabapentin Product Market Performance
9.8.4 Sun Pharmaceutical Business Overview
9.8.5 Sun Pharmaceutical Recent Developments
9.9 Aurobindo Pharma
9.9.1 Aurobindo Pharma Gabapentin Basic Information
9.9.2 Aurobindo Pharma Gabapentin Product Overview
9.9.3 Aurobindo Pharma Gabapentin Product Market Performance
9.9.4 Aurobindo Pharma Business Overview
9.9.5 Aurobindo Pharma Recent Developments
9.10 Intas
9.10.1 Intas Gabapentin Basic Information
9.10.2 Intas Gabapentin Product Overview
9.10.3 Intas Gabapentin Product Market Performance
9.10.4 Intas Business Overview
9.10.5 Intas Recent Developments
9.11 Amneal
9.11.1 Amneal Gabapentin Basic Information
9.11.2 Amneal Gabapentin Product Overview
9.11.3 Amneal Gabapentin Product Market Performance
9.11.4 Amneal Business Overview
9.11.5 Amneal Recent Developments
9.12 Marksans Pharma
9.12.1 Marksans Pharma Gabapentin Basic Information
9.12.2 Marksans Pharma Gabapentin Product Overview
9.12.3 Marksans Pharma Gabapentin Product Market Performance
9.12.4 Marksans Pharma Business Overview
9.12.5 Marksans Pharma Recent Developments
9.13 Glenmark
9.13.1 Glenmark Gabapentin Basic Information
9.13.2 Glenmark Gabapentin Product Overview
9.13.3 Glenmark Gabapentin Product Market Performance
9.13.4 Glenmark Business Overview
9.13.5 Glenmark Recent Developments
9.14 Alkem
9.14.1 Alkem Gabapentin Basic Information
9.14.2 Alkem Gabapentin Product Overview
9.14.3 Alkem Gabapentin Product Market Performance
9.14.4 Alkem Business Overview
9.14.5 Alkem Recent Developments
9.15 Jiangsu Enhua
9.15.1 Jiangsu Enhua Gabapentin Basic Information
9.15.2 Jiangsu Enhua Gabapentin Product Overview
9.15.3 Jiangsu Enhua Gabapentin Product Market Performance
9.15.4 Jiangsu Enhua Business Overview
9.15.5 Jiangsu Enhua Recent Developments
9.16 Jiangsu Hengrui
9.16.1 Jiangsu Hengrui Gabapentin Basic Information
9.16.2 Jiangsu Hengrui Gabapentin Product Overview
9.16.3 Jiangsu Hengrui Gabapentin Product Market Performance
9.16.4 Jiangsu Hengrui Business Overview
9.16.5 Jiangsu Hengrui Recent Developments
9.17 Sailike
9.17.1 Sailike Gabapentin Basic Information
9.17.2 Sailike Gabapentin Product Overview
9.17.3 Sailike Gabapentin Product Market Performance
9.17.4 Sailike Business Overview
9.17.5 Sailike Recent Developments
10 GABAPENTIN MARKET FORECAST BY REGION
10.1 Global Gabapentin Market Size Forecast
10.2 Global Gabapentin Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gabapentin Market Size Forecast by Country
10.2.3 Asia Pacific Gabapentin Market Size Forecast by Region
10.2.4 South America Gabapentin Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gabapentin by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gabapentin Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gabapentin by Type (2025-2030)
11.1.2 Global Gabapentin Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gabapentin by Type (2025-2030)
11.2 Global Gabapentin Market Forecast by Application (2025-2030)
11.2.1 Global Gabapentin Sales (Kilotons) Forecast by Application
11.2.2 Global Gabapentin Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gabapentin Market Size Comparison by Region (M USD)
Table 5. Global Gabapentin Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gabapentin Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gabapentin Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gabapentin Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2022)
Table 10. Global Market Gabapentin Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gabapentin Sales Sites and Area Served
Table 12. Manufacturers Gabapentin Product Type
Table 13. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gabapentin
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Market Challenges
Table 22. Global Gabapentin Sales by Type (Kilotons)
Table 23. Global Gabapentin Market Size by Type (M USD)
Table 24. Global Gabapentin Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gabapentin Sales Market Share by Type (2019-2024)
Table 26. Global Gabapentin Market Size (M USD) by Type (2019-2024)
Table 27. Global Gabapentin Market Size Share by Type (2019-2024)
Table 28. Global Gabapentin Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gabapentin Sales (Kilotons) by Application
Table 30. Global Gabapentin Market Size by Application
Table 31. Global Gabapentin Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gabapentin Sales Market Share by Application (2019-2024)
Table 33. Global Gabapentin Sales by Application (2019-2024) & (M USD)
Table 34. Global Gabapentin Market Share by Application (2019-2024)
Table 35. Global Gabapentin Sales Growth Rate by Application (2019-2024)
Table 36. Global Gabapentin Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gabapentin Sales Market Share by Region (2019-2024)
Table 38. North America Gabapentin Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gabapentin Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gabapentin Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gabapentin Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gabapentin Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Gabapentin Basic Information
Table 44. Pfizer Gabapentin Product Overview
Table 45. Pfizer Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Gabapentin SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Assertio Therapeutics Gabapentin Basic Information
Table 50. Assertio Therapeutics Gabapentin Product Overview
Table 51. Assertio Therapeutics Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Assertio Therapeutics Business Overview
Table 53. Assertio Therapeutics Gabapentin SWOT Analysis
Table 54. Assertio Therapeutics Recent Developments
Table 55. TEVA Gabapentin Basic Information
Table 56. TEVA Gabapentin Product Overview
Table 57. TEVA Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. TEVA Gabapentin SWOT Analysis
Table 59. TEVA Business Overview
Table 60. TEVA Recent Developments
Table 61. Mylan Gabapentin Basic Information
Table 62. Mylan Gabapentin Product Overview
Table 63. Mylan Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mylan Business Overview
Table 65. Mylan Recent Developments
Table 66. Arbor Pharma Gabapentin Basic Information
Table 67. Arbor Pharma Gabapentin Product Overview
Table 68. Arbor Pharma Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Arbor Pharma Business Overview
Table 70. Arbor Pharma Recent Developments
Table 71. Novartis Gabapentin Basic Information
Table 72. Novartis Gabapentin Product Overview
Table 73. Novartis Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Apotex Gabapentin Basic Information
Table 77. Apotex Gabapentin Product Overview
Table 78. Apotex Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Apotex Business Overview
Table 80. Apotex Recent Developments
Table 81. Sun Pharmaceutical Gabapentin Basic Information
Table 82. Sun Pharmaceutical Gabapentin Product Overview
Table 83. Sun Pharmaceutical Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sun Pharmaceutical Business Overview
Table 85. Sun Pharmaceutical Recent Developments
Table 86. Aurobindo Pharma Gabapentin Basic Information
Table 87. Aurobindo Pharma Gabapentin Product Overview
Table 88. Aurobindo Pharma Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Recent Developments
Table 91. Intas Gabapentin Basic Information
Table 92. Intas Gabapentin Product Overview
Table 93. Intas Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Intas Business Overview
Table 95. Intas Recent Developments
Table 96. Amneal Gabapentin Basic Information
Table 97. Amneal Gabapentin Product Overview
Table 98. Amneal Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Amneal Business Overview
Table 100. Amneal Recent Developments
Table 101. Marksans Pharma Gabapentin Basic Information
Table 102. Marksans Pharma Gabapentin Product Overview
Table 103. Marksans Pharma Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Marksans Pharma Business Overview
Table 105. Marksans Pharma Recent Developments
Table 106. Glenmark Gabapentin Basic Information
Table 107. Glenmark Gabapentin Product Overview
Table 108. Glenmark Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Glenmark Business Overview
Table 110. Glenmark Recent Developments
Table 111. Alkem Gabapentin Basic Information
Table 112. Alkem Gabapentin Product Overview
Table 113. Alkem Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Alkem Business Overview
Table 115. Alkem Recent Developments
Table 116. Jiangsu Enhua Gabapentin Basic Information
Table 117. Jiangsu Enhua Gabapentin Product Overview
Table 118. Jiangsu Enhua Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Jiangsu Enhua Business Overview
Table 120. Jiangsu Enhua Recent Developments
Table 121. Jiangsu Hengrui Gabapentin Basic Information
Table 122. Jiangsu Hengrui Gabapentin Product Overview
Table 123. Jiangsu Hengrui Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Jiangsu Hengrui Business Overview
Table 125. Jiangsu Hengrui Recent Developments
Table 126. Sailike Gabapentin Basic Information
Table 127. Sailike Gabapentin Product Overview
Table 128. Sailike Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Sailike Business Overview
Table 130. Sailike Recent Developments
Table 131. Global Gabapentin Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Gabapentin Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Gabapentin Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Gabapentin Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Gabapentin Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Gabapentin Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Gabapentin Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Gabapentin Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Gabapentin Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Gabapentin Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Gabapentin Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Gabapentin Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Gabapentin Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gabapentin Market Size Comparison by Region (M USD)
Table 5. Global Gabapentin Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gabapentin Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gabapentin Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gabapentin Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2022)
Table 10. Global Market Gabapentin Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gabapentin Sales Sites and Area Served
Table 12. Manufacturers Gabapentin Product Type
Table 13. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gabapentin
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gabapentin Market Challenges
Table 22. Global Gabapentin Sales by Type (Kilotons)
Table 23. Global Gabapentin Market Size by Type (M USD)
Table 24. Global Gabapentin Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gabapentin Sales Market Share by Type (2019-2024)
Table 26. Global Gabapentin Market Size (M USD) by Type (2019-2024)
Table 27. Global Gabapentin Market Size Share by Type (2019-2024)
Table 28. Global Gabapentin Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gabapentin Sales (Kilotons) by Application
Table 30. Global Gabapentin Market Size by Application
Table 31. Global Gabapentin Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gabapentin Sales Market Share by Application (2019-2024)
Table 33. Global Gabapentin Sales by Application (2019-2024) & (M USD)
Table 34. Global Gabapentin Market Share by Application (2019-2024)
Table 35. Global Gabapentin Sales Growth Rate by Application (2019-2024)
Table 36. Global Gabapentin Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gabapentin Sales Market Share by Region (2019-2024)
Table 38. North America Gabapentin Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gabapentin Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gabapentin Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gabapentin Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gabapentin Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Gabapentin Basic Information
Table 44. Pfizer Gabapentin Product Overview
Table 45. Pfizer Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Gabapentin SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Assertio Therapeutics Gabapentin Basic Information
Table 50. Assertio Therapeutics Gabapentin Product Overview
Table 51. Assertio Therapeutics Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Assertio Therapeutics Business Overview
Table 53. Assertio Therapeutics Gabapentin SWOT Analysis
Table 54. Assertio Therapeutics Recent Developments
Table 55. TEVA Gabapentin Basic Information
Table 56. TEVA Gabapentin Product Overview
Table 57. TEVA Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. TEVA Gabapentin SWOT Analysis
Table 59. TEVA Business Overview
Table 60. TEVA Recent Developments
Table 61. Mylan Gabapentin Basic Information
Table 62. Mylan Gabapentin Product Overview
Table 63. Mylan Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Mylan Business Overview
Table 65. Mylan Recent Developments
Table 66. Arbor Pharma Gabapentin Basic Information
Table 67. Arbor Pharma Gabapentin Product Overview
Table 68. Arbor Pharma Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Arbor Pharma Business Overview
Table 70. Arbor Pharma Recent Developments
Table 71. Novartis Gabapentin Basic Information
Table 72. Novartis Gabapentin Product Overview
Table 73. Novartis Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Apotex Gabapentin Basic Information
Table 77. Apotex Gabapentin Product Overview
Table 78. Apotex Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Apotex Business Overview
Table 80. Apotex Recent Developments
Table 81. Sun Pharmaceutical Gabapentin Basic Information
Table 82. Sun Pharmaceutical Gabapentin Product Overview
Table 83. Sun Pharmaceutical Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sun Pharmaceutical Business Overview
Table 85. Sun Pharmaceutical Recent Developments
Table 86. Aurobindo Pharma Gabapentin Basic Information
Table 87. Aurobindo Pharma Gabapentin Product Overview
Table 88. Aurobindo Pharma Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Aurobindo Pharma Business Overview
Table 90. Aurobindo Pharma Recent Developments
Table 91. Intas Gabapentin Basic Information
Table 92. Intas Gabapentin Product Overview
Table 93. Intas Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Intas Business Overview
Table 95. Intas Recent Developments
Table 96. Amneal Gabapentin Basic Information
Table 97. Amneal Gabapentin Product Overview
Table 98. Amneal Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Amneal Business Overview
Table 100. Amneal Recent Developments
Table 101. Marksans Pharma Gabapentin Basic Information
Table 102. Marksans Pharma Gabapentin Product Overview
Table 103. Marksans Pharma Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Marksans Pharma Business Overview
Table 105. Marksans Pharma Recent Developments
Table 106. Glenmark Gabapentin Basic Information
Table 107. Glenmark Gabapentin Product Overview
Table 108. Glenmark Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Glenmark Business Overview
Table 110. Glenmark Recent Developments
Table 111. Alkem Gabapentin Basic Information
Table 112. Alkem Gabapentin Product Overview
Table 113. Alkem Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Alkem Business Overview
Table 115. Alkem Recent Developments
Table 116. Jiangsu Enhua Gabapentin Basic Information
Table 117. Jiangsu Enhua Gabapentin Product Overview
Table 118. Jiangsu Enhua Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Jiangsu Enhua Business Overview
Table 120. Jiangsu Enhua Recent Developments
Table 121. Jiangsu Hengrui Gabapentin Basic Information
Table 122. Jiangsu Hengrui Gabapentin Product Overview
Table 123. Jiangsu Hengrui Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Jiangsu Hengrui Business Overview
Table 125. Jiangsu Hengrui Recent Developments
Table 126. Sailike Gabapentin Basic Information
Table 127. Sailike Gabapentin Product Overview
Table 128. Sailike Gabapentin Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Sailike Business Overview
Table 130. Sailike Recent Developments
Table 131. Global Gabapentin Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Gabapentin Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Gabapentin Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Gabapentin Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Gabapentin Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Gabapentin Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Gabapentin Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Gabapentin Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Gabapentin Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Gabapentin Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Gabapentin Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Gabapentin Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Gabapentin Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Gabapentin Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gabapentin
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Market Size (M USD), 2019-2030
Figure 5. Global Gabapentin Market Size (M USD) (2019-2030)
Figure 6. Global Gabapentin Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Market Size by Country (M USD)
Figure 11. Gabapentin Sales Share by Manufacturers in 2023
Figure 12. Global Gabapentin Revenue Share by Manufacturers in 2023
Figure 13. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gabapentin Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gabapentin Market Share by Type
Figure 18. Sales Market Share of Gabapentin by Type (2019-2024)
Figure 19. Sales Market Share of Gabapentin by Type in 2023
Figure 20. Market Size Share of Gabapentin by Type (2019-2024)
Figure 21. Market Size Market Share of Gabapentin by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gabapentin Market Share by Application
Figure 24. Global Gabapentin Sales Market Share by Application (2019-2024)
Figure 25. Global Gabapentin Sales Market Share by Application in 2023
Figure 26. Global Gabapentin Market Share by Application (2019-2024)
Figure 27. Global Gabapentin Market Share by Application in 2023
Figure 28. Global Gabapentin Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gabapentin Sales Market Share by Region (2019-2024)
Figure 30. North America Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gabapentin Sales Market Share by Country in 2023
Figure 32. U.S. Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gabapentin Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gabapentin Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gabapentin Sales Market Share by Country in 2023
Figure 37. Germany Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gabapentin Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gabapentin Sales Market Share by Region in 2023
Figure 44. China Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gabapentin Sales and Growth Rate (Kilotons)
Figure 50. South America Gabapentin Sales Market Share by Country in 2023
Figure 51. Brazil Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gabapentin Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gabapentin Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gabapentin Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gabapentin Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gabapentin Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gabapentin Market Share Forecast by Type (2025-2030)
Figure 65. Global Gabapentin Sales Forecast by Application (2025-2030)
Figure 66. Global Gabapentin Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gabapentin
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Market Size (M USD), 2019-2030
Figure 5. Global Gabapentin Market Size (M USD) (2019-2030)
Figure 6. Global Gabapentin Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Market Size by Country (M USD)
Figure 11. Gabapentin Sales Share by Manufacturers in 2023
Figure 12. Global Gabapentin Revenue Share by Manufacturers in 2023
Figure 13. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gabapentin Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gabapentin Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gabapentin Market Share by Type
Figure 18. Sales Market Share of Gabapentin by Type (2019-2024)
Figure 19. Sales Market Share of Gabapentin by Type in 2023
Figure 20. Market Size Share of Gabapentin by Type (2019-2024)
Figure 21. Market Size Market Share of Gabapentin by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gabapentin Market Share by Application
Figure 24. Global Gabapentin Sales Market Share by Application (2019-2024)
Figure 25. Global Gabapentin Sales Market Share by Application in 2023
Figure 26. Global Gabapentin Market Share by Application (2019-2024)
Figure 27. Global Gabapentin Market Share by Application in 2023
Figure 28. Global Gabapentin Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gabapentin Sales Market Share by Region (2019-2024)
Figure 30. North America Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gabapentin Sales Market Share by Country in 2023
Figure 32. U.S. Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gabapentin Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gabapentin Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gabapentin Sales Market Share by Country in 2023
Figure 37. Germany Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gabapentin Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gabapentin Sales Market Share by Region in 2023
Figure 44. China Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gabapentin Sales and Growth Rate (Kilotons)
Figure 50. South America Gabapentin Sales Market Share by Country in 2023
Figure 51. Brazil Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gabapentin Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gabapentin Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gabapentin Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gabapentin Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gabapentin Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gabapentin Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gabapentin Market Share Forecast by Type (2025-2030)
Figure 65. Global Gabapentin Sales Forecast by Application (2025-2030)
Figure 66. Global Gabapentin Market Share Forecast by Application (2025-2030)
